person

Emeline T.

Country
France
Department
Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
52
Sites with multiple studies

Has run more than one trial at 52 of 141 partner sites.

Specializations

Brain Cancer Research

The investigator specializes in the treatment of glioblastoma, focusing on innovative therapeutic approaches for both newly diagnosed and recurrent cases. Their expertise extends to the development of targeted treatments using temozolomide-based combination therapies.

  • MGMT unmethylated glioblastoma treatments
  • Maintenance therapy optimization
  • Novel drug combinations

Their work encompasses evaluation of emerging treatments including Tumor Treating Fields (Optune) and immunotherapy applications.

Pediatric Neuro-Oncology

The investigator focuses on rare pediatric brain tumors, particularly diffuse intrinsic pontine glioma (DIPG) and other diffuse midline gliomas. Their research includes targeted biological therapies for children and adolescents with these challenging conditions.

  • H3K28M mutant gliomas
  • EZHIP positive tumors
  • Radiotherapy combinations

Their work integrates molecular diagnostics with therapeutic interventions for pediatric brain cancer treatment.

Advanced Brain Tumor Therapies

The investigator explores treatments for recurrent meningioma, including innovative approaches such as radioligand therapy. Their research encompasses both conventional and experimental therapeutic modalities for complex brain tumors.

  • Lutathera treatment applications
  • Alternative treatment strategies
  • Refractory tumor management

Their expertise includes evaluation of treatment options for patients without conventional surgical or radiotherapy alternatives.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.